Aspira Women’s Health Executes an Agreement with Axia Women’s Health to Launch Aspira Synergy Genetics Platform

Axia Women’s Overall health is one particular of the major women’s health and fitness networks in the United States serving nearly half a million gals a 12 months

AUSTIN, Texas, Jan. 05, 2022 (Globe NEWSWIRE) — Aspira Women’s Overall health Inc. (Nasdaq: AWH), a bioanalytical-primarily based women’s wellbeing corporation, declared currently that it has entered into a professional company agreement with Axia Women’s Health and fitness, just one of the nation’s major and main impartial women’s healthcare groups. Axia Women’s Wellness is an revolutionary and progressive community of more than 400 suppliers and 150 women’s overall health facilities across New Jersey, Pennsylvania, Indiana, Ohio, and Kentucky. Axia Women’s Overall health suppliers offer you companies across the treatment continuum including obstetrics, gynecology, mammography, urogynecology, fertility, and other sub-specialties.

Below the five-year arrangement, Axia Women’s Wellbeing providers will have the capacity to conduct genetic screening in-house making use of the proprietary Aspira Synergy Genetics system. This will allow for Axia Women’s Wellbeing vendors to offer provider screening products and services to the nearly 50 {6f90f2fe98827f97fd05e0011472e53c8890931f9d0d5714295052b72b9b5161} a million clients they provide.

Aspira Synergy Genetics is a genetics-focused, novel know-how transfer answer that features tailor made Upcoming Era Sequencing (NGS) chemistry paired with proprietary cloud-dependent bioinformatics that ended up developed for the Aspira Synergy system. Clientele can obtain separately custom made, targeted, and comprehensive panels for expanded carrier screening and hereditary cancers which are both of those accessible on the exact biochemistry and analytical pipeline. The Aspira Synergy Genetics alternative can generate these personalized, higher-top quality scientific genetics stories for the laboratory, referring medical professionals, and people.

“We are incredibly fired up to offer you our groundbreaking worldwide engineering to Axia Women’s Wellbeing, 1 of the nation’s top women’s health networks. The Aspira Synergy Genetics platform leverages novel biochemistry with a clinical-grade AI-based mostly bioinformatics to provide genetics intelligence,” explained Valerie Palmieri, President and CEO of Aspira Women’s Health and fitness Inc. “By furnishing proactive personalised possibility evaluation at the level of treatment, we are assisting suppliers to regulate their clients and their families’ germline threats as early as probable. Proactive possibility detection is a main mission of our firm.”

Story proceeds

The Aspira Synergy platform, which is made up of genetics and specialty testing remedies, is a decentralized system that empowers health practitioner teams, health care techniques, and regional laboratories to offer you specialised tests that could usually not be obtainable. The Aspira Synergy system fulfills demanding privateness requirements, makes use of AI technologies, and is really scalable to accommodate the escalating need for clinical genetic and genomic tests as effectively as OVA1plus™. OVA1as well as combines the Fda-cleared products OVA1® and OVERA® for evaluating ovarian cancer possibility in women of all ages with pelvic masses.

“The science driving creating the Aspira Synergy system is to be universal to all of the Aspira Women’s Wellness assays, making it possible for our clientele to give our very best clinical diagnostic tests companies right to their clients, meeting the benchmarks and good quality found in a significant-excellent specialty laboratory,” said Lesley E. Northrop, Ph.D., FACMG, Aspira Women’s Health’s Main Scientific Officer. Aspira Women’s Overall health is developing a robust suite of gynecologic examination options, which include OVAWatch™ for ovarian most cancers possibility evaluation and EndoCheck™ for endometriosis.

Dr. Elizabeth Cherot, M.D., Main Professional medical Officer of Axia Women’s Health and fitness commented, “Our partnership with Aspira Women’s Wellbeing permits us to even further our mission of delivering more connected and far more progressive care to the gals in our group. We appear forward to giving the benefit of this genetic testing to our patients, along with the steerage and aid of our trustworthy providers, to assistance discover prospective wellbeing challenges and in the end improve overall health results.”

About Aspira Women’s Wellbeing Inc.
Aspira Women’s Wellness Inc. is transforming women’s wellbeing with the discovery, development, and commercialization of ground breaking tests alternatives and bio-analytical solutions that support doctors assess hazard, improve affected person administration, and make improvements to gynecologic health and fitness results for ladies. Aspira Women’s Well being is significantly focused on closing the ethnic disparity hole in ovarian cancer risk assessment and producing remedies for pelvic health conditions these as pelvic mass threat evaluation and endometriosis. OVA1plus™ combines our Fda-cleared products, OVA1® and OVERA®, to detect danger of ovarian malignancy in girls with adnexal masses. Aspira GenetiX™ tests features both equally targeted and comprehensive genetic testing selections with a gynecologic emphasis. With over 10 decades of expertise in ovarian cancer risk assessment, Aspira Women’s Health is doing work to deliver a portfolio of pelvic mass products and solutions around a patient’s life span with our slicing-edge research. The subsequent technology of goods in enhancement contain OVAWatch™ and EndoCheck™. To boost client accessibility, Aspira Women’s Health and fitness has not long ago launched our Aspira Synergy know-how transfer platform to empower well being programs, lecturers, regional labs, and medical doctor team labs to conduct genetic and specialty tests in-home. Visit our web-site for far more details at www.aspirawh.com.

About Axia Women’s Well being
Axia Women’s Health is main the way in bettering women’s overall health. At the main of accomplishing this is a caring, connected, and progressive local community of 400 suppliers across 150 women’s wellbeing facilities in New Jersey, Pennsylvania, Indiana, Ohio, and Kentucky. The speedily expanding community spans OB/GYN medical professionals, breast wellness facilities, substantial-chance pregnancy centers, two laboratories, urogynecology, and fertility facilities. Alongside one another, Axia Women’s Well being puts females to start with by providing the personalised care necessary for gals to lead healthier, happier lives. Discover extra at www.AxiaWH.com.

Ahead-Seeking Statements
This press release is made up of ahead-seeking statements, as outlined in the Private Securities Litigation Reform Act of 1995, including statements concerning the envisioned use of Aspira Synergy Genetics by Axia Women’s Health doctors. These statements involve a number of threats and uncertainties. All statements other than statements of historic information contained in this push launch are ahead-hunting statements. Text these types of as “may,” “expects,” “intends,” “anticipates,” “believes,” “estimates,” “plans,” “seeks,” “could,” “should,” “continue,” “will,” “potential,” “projects” and equivalent expressions are supposed to recognize forward-hunting statements. These forward-searching statements converse only as of the date of this push release and are matter to a amount of pitfalls, uncertainties, and assumptions, which includes the threats and uncertainties explained in the part entitled “Risk Factors” in Aspira Women’s Health’s Yearly Report on Sort 10-K for the calendar year ended December 31, 2020 and Quarterly Report on Sort 10-Q for the quarter finished June 30, 2021. The situations and situation mirrored in Aspira Women’s Health’s forward-wanting statements might not be obtained or arise and true effects could differ materially from these projected in the ahead-looking statements. Aspira Women’s Health and fitness expressly disclaims any obligation to update, amend or clarify any ahead-looking statements to mirror situations, new info or instances occurring after the date of this push release, besides as demanded by regulation.

Investor Relations Get hold of:
Ashley R. Robinson
LifeSci Advisors, LLC
Tel 617-430-7577
[email protected]